Document Type
Blog Post
Publication Date
1-8-2016
Disciplines
Nervous System Diseases
Digital USD Citation
Serbin, Kenneth P., "A key Huntington’s disease trial remedy gets Orphan Drug Designation, as yet another young life is cut short" (2016). At Risk for Huntington's Disease. 220.
https://digital.sandiego.edu/huntingtons/220
